Company intelligence / Profile preview

Peili Vision

Ownership: Private
Development stage: Commercial

Overview

Peili Vision’s flagship product, EFSim, is a scientifically validated, web-based simulation test for assessing executive function deficits related to ADHD. Clinical trials have demonstrated 92% diagnostic accuracy and a 43% reduction in waiting times for ADHD assessments. The solution is UKCA-certified and will soon be CE-marked under MDR II for the EU market.

Therapeutic areas: PsychiatryNeurology
Modalities: DeviceNon-pharmacological therapy (digital diagnostic/assessment tool)
Industry: Digital Health Medical Devices

Partnerships

Aurevia/Labquality (CRO partner for clinical studies)

Beyond the preview

Go deeper on Peili Vision.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Peili Vision.

Explore the full profile